Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 10/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27859351 | 0.88 | CYP3A4 (0.44) | DRD2DRD1TAAR1CALM1ALDH1A1 | |
| Resorcinol SCHEMBL3731090 | 0.86 | ALDH1A1 (0.47) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL21164067 | 0.84 | CYP3A4 (0.46) | DRD2DRD1TAAR1CALM1ALDH1A1 | |
| Resorcinol SCHEMBL37801 | 0.84 | ALDH1A1 (0.52) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| Resorcinol SCHEMBL28826037 | 0.84 | ALDH1A1 (0.52) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| Hydroquinone SCHEMBL17275035 | 0.83 | MEN1 (0.40) | CALM1ALDH1A1TP53CYP3A4TSHR | |
| Resorcinol SCHEMBL27815945 | 0.82 | ALDH1A1 (0.50) | ALDH1A1TP53CYP3A4TSHRSMN1; SMN2 | |
| SCHEMBL11495578 | 0.82 | SPHK2 (0.48) | DRD2ALDH1A1CYP3A4OPRK1OPRM1 | |
| Tyrosol SCHEMBL732381 | 0.81 | CA2 (0.57) | TAAR1ALDH1A1TSHR | |
| Hydroquinone SCHEMBL17274944 | 0.81 | CA2 (0.57) | TAAR1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2788398-B1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | SUN CHEMICAL CORP (US) | 2018-07-25 | — | — | EP | claimed |
| US-9624380-B2 | Sulfide extended epoxy resins and barrier coating applications thereof | SUN CHEMICAL CORPORATION (US) | 2017-04-18 | — | — | US | claimed |
| US-20140370220-A1 | OVERPRINT VARNISHES WITH NON-AQUOUS DISPERSIONS | SUN CHEMICAL CORPORATION (US) | 2014-12-18 | — | — | US | claimed |
| US-20140342091-A1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATING APPLICATIONS THEREOF | SUN CHEMICAL CORPORATION (US) | 2014-11-20 | — | — | US | claimed |
| EP-2788398-A2 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | Sun Chemical Corporation (US) | 2014-10-15 | — | — | EP | claimed |
| CN-104039862-A | Sulfide-extended epoxy resin and application of barrier coating thereof | SUN CHEMICAL CORP | 2014-09-10 | — | — | CN | claimed |
| WO-2013090702-A2 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | SUN CHEMICAL CORPORATION (US) | 2013-06-20 | — | — | WO | claimed |
| EP-2788398-B1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | SUN CHEMICAL CORP (US) | 2018-07-25 | — | — | EP | disclosed |
| US-9624380-B2 | Sulfide extended epoxy resins and barrier coating applications thereof | SUN CHEMICAL CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-20140342091-A1 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATING APPLICATIONS THEREOF | SUN CHEMICAL CORPORATION (US) | 2014-11-20 | — | — | US | disclosed |
| US-8889802-B2 | Polymer compositions and methods of making and using same | POLYMERIGHT, INC. (US) | 2014-11-18 | — | — | US | disclosed |
| EP-2788398-A2 | SULFIDE EXTENDED EPOXY RESINS AND BARRIER COATINGS APPLICATIONS THEREOF | Sun Chemical Corporation (US) | 2014-10-15 | — | — | EP | disclosed |
| CN-104039862-A | Sulfide-extended epoxy resin and application of barrier coating thereof | SUN CHEMICAL CORP | 2014-09-10 | — | — | CN | disclosed |
| WO-2011008480-A1 | POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME | POLYMERIGHT, INC. (US) | 2011-01-20 | — | — | WO | disclosed |
| WO-2009132010-A1 | METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-29 | — | — | WO | disclosed |
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2009-10-22 | — | — | US | disclosed |
| CN-101309992-A | Mercaptan-hardened epoxy polymer compositions and processes for making and using same | CHEVRON PHILLIPS CHEMICAL CO (US) | 2008-11-19 | — | — | CN | disclosed |
| EP-1940992-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2008-07-09 | — | — | EP | disclosed |
| US-20070112100-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY, LP | 2007-05-17 | — | — | US | disclosed |
| WO-2007022217-A1 | MERCAPTAN-HARDENED EPOXY POLYMER COMPOSITIONS AND PROCESSES FOR MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090264669-A1 | Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds | TST, HHAT, GSTO1 | DRD2 3448/4885DRD1 3355/4885TAAR1 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.